Oncología Hepática
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
Madrid, EspañaPublications in collaboration with researchers from Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (182)
2024
-
Application of Graph Models to the Identification of Transcriptomic Oncometabolic Pathways in Human Hepatocellular Carcinoma
Biomolecules, Vol. 14, Núm. 6
-
Caspases compromise SLU7 and UPF1 stability and NMD activity during hepatocarcinogenesis
JHEP Reports, Vol. 6, Núm. 8
-
Circulating miR-122-5p, miR-151a-3p, miR-126-5p and miR-21-5p as potential predictive biomarkers for Metabolic Dysfunction-Associated Steatotic Liver Disease assessment
Journal of Physiology and Biochemistry
-
Comprehensive in silico CpG methylation analysis in hepatocellular carcinoma identifies tissue- and tumor-type specific marks disconnected from gene expression
Journal of Physiology and Biochemistry
-
Evidence and choice: The BCLC vision for tailoring clinical decision-making
Journal of Hepatology
-
Identification of PRMT5 as a therapeutic target in cholangiocarcinoma
Gut
-
Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU
Gastroenterologia y Hepatologia, Vol. 47, Núm. 4, pp. 401-432
-
New insights into the regulation of bile acids synthesis during the early stages of liver regeneration: A human and experimental study
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 5
-
Repeated pancreatic resection for pancreatic metastases from renal cell Carcinoma: A Spanish multicenter study (PANMEKID)
Surgical Oncology, Vol. 52
-
The ‘BCLC upon progression’ classification: After repeated validation, it is time to incorporate it in trial design
Liver International
-
Time since liver transplant and immunosuppression withdrawal outcomes: Systematic review and individual patient data meta-analysis
Liver International, Vol. 44, Núm. 1, pp. 250-262
2023
-
Alternative forms of portal vein revascularization in liver transplant recipients with complex portal vein thrombosis
Journal of Hepatology, Vol. 78, Núm. 4, pp. 794-804
-
Comprehensive analysis of epigenetic and epitranscriptomic genes’ expression in human NAFLD
Journal of Physiology and Biochemistry, Vol. 79, Núm. 4, pp. 901-924
-
Identification and experimental validation of druggable epigenetic targets in hepatoblastoma
Journal of Hepatology, Vol. 79, Núm. 4, pp. 989-1005
-
Impact of body composition in advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trial
HEPATOLOGY COMMUNICATIONS, Vol. 7, Núm. 6
-
Isoliquiritigenin in combination with visceral adipose tissue and related markers as a predictive tool for nonalcoholic fatty liver disease
Journal of Physiology and Biochemistry
-
Mapping early serum proteome signatures of liver regeneration in living donor liver transplant cases
BioFactors, Vol. 49, Núm. 4, pp. 912-927
-
Metabolic dysfunction–associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment
Journal of Physiology and Biochemistry, Vol. 79, Núm. 4, pp. 869-879
-
Nivolumab Plus Cabozantinib with or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results from Cohort 6 of the CheckMate 040 Trial
Journal of Clinical Oncology
-
Partial Radiation Nephrectomy Using 90Y Resin Microspheres: A Treatment Option for Renal Tumors With Malignant Characteristics in Patients Not Candidates for Surgery
Clinical Nuclear Medicine, Vol. 48, Núm. 11, pp. 960-962